A randomised placebo-controlled trial of topical cysteamine therapy in patients with nephropathic cystinosis
Authors:
- Jean-Pierre DanjouxJDJean-Pierre Danjoux
- Jean VollerJVJean Voller
- 1 November 1991
- journal article
- case report
- Published by Springer Nature in Eye
- Vol. 5 (6) , 755-760
Abstract
Five patients with nephropathic cystinosis were evaluated to assess the ability of topical cysteamine to clear corneal cystine crystals. All patients were randomised to receive topical cysteamine 0.2% six times a day in one eye with normal saline in the other eye as a control. All five patients showed some improvement in visual symptoms (photophobia, ble-pharospasm and visual acuity) together with an improvement in corneal crystal density. Three of these also had an improvement in Snellen visual acuity and contrast sensitivity.Keywords
This publication has 7 references indexed in Scilit:
- The Effect of Topical Cysteamine Drops on Reducing Crystal Formation Within the Cornea of Patients Affected by Nephropathic CystinosisJournal of Pediatric Ophthalmology & Strabismus, 1990
- A Randomized Placebo-Controlled Trial of Cysteamine Eye Drops in Nephropathic CystinosisArchives of Ophthalmology (1950), 1990
- Cystinosis: Progress in a Prototypic DiseaseAnnals of Internal Medicine, 1988
- Glare Disability in Nephropathic CystinosisArchives of Ophthalmology (1950), 1987
- Contrast Sensitivity Function in Nephropathic CystinosisArchives of Ophthalmology (1950), 1987
- Cysteamine Therapy for Children with Nephropathic CystinosisNew England Journal of Medicine, 1987
- Removal of Corneal Crystals by Topical Cysteamine in Nephropathic CystinosisNew England Journal of Medicine, 1987